{"id":25774,"date":"2024-10-10T14:37:13","date_gmt":"2024-10-10T12:37:13","guid":{"rendered":"https:\/\/mabdesign.fr\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/"},"modified":"2024-10-10T14:37:28","modified_gmt":"2024-10-10T12:37:28","slug":"ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/","title":{"rendered":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system"},"content":{"rendered":"\n<p>Evry, France, October 10, 2024 \u2013 AGS Therapeutics, a preclinical-stage biotech company pioneering<br>microalgae extracellular vesicles (MEVs) as a new, universal delivery system, today announced<br>that it has entered into an agreement with Sanofi, in the context of the 2024 iDEA-TECH Awards.<br>AGS will thus embark on a twelve-month collaborative research project together with scientific<br>experts at Sanofi\u2019s Vaccine business unit to further validate AGS\u2019 MEVs against undisclosed targets,<br>in general, and as a vaccinal delivery system for oral-intestinal mucosal vaccination, in particular.<br>This collaborative work leverages the unique capabilities of AGS\u2019 MEVs and the strength of AGS\u2019<br>intellectual property in the vaccination and immunomodulation fields (cf. PR from October 1, 2024,<br>on the publication of the relevant patent). <a href=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/10\/2024-10-08_Mucosal-Vaccination_iDea-Tech-award-Sanofi_AGS.pdf\">To know more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system<\/p>\n","protected":false},"author":3,"featured_media":21411,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32],"tags":[],"class_list":["post-25774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-our-members"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign<\/title>\n<meta name=\"description\" content=\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign\" \/>\n<meta property=\"og:description\" content=\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-10T12:37:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-10T12:37:28+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Laure Delhon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laure Delhon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\"},\"author\":{\"name\":\"Laure Delhon\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\"},\"headline\":\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system\",\"datePublished\":\"2024-10-10T12:37:13+00:00\",\"dateModified\":\"2024-10-10T12:37:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\"},\"wordCount\":136,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png\",\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\",\"name\":\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png\",\"datePublished\":\"2024-10-10T12:37:13+00:00\",\"dateModified\":\"2024-10-10T12:37:28+00:00\",\"description\":\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png\",\"width\":300,\"height\":160},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\",\"name\":\"Laure Delhon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"caption\":\"Laure Delhon\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign","description":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/","og_locale":"en_US","og_type":"article","og_title":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign","og_description":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system","og_url":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/","og_site_name":"MabDesign","article_published_time":"2024-10-10T12:37:13+00:00","article_modified_time":"2024-10-10T12:37:28+00:00","og_image":[{"width":300,"height":160,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png","type":"image\/png"}],"author":"Laure Delhon","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Laure Delhon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/"},"author":{"name":"Laure Delhon","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39"},"headline":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system","datePublished":"2024-10-10T12:37:13+00:00","dateModified":"2024-10-10T12:37:28+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/"},"wordCount":136,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png","articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/","url":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/","name":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png","datePublished":"2024-10-10T12:37:13+00:00","dateModified":"2024-10-10T12:37:28+00:00","description":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/01\/AGS-Therapeutics-1-5-1-300x160-1.png","width":300,"height":160},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/ags-therapeutics-to-collaborate-with-sanofi-on-intestinal-mucosal-vaccination-by-oral-administration-using-ags-mev-technology-as-a-vaccinal-delivery-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"AGS Therapeutics to collaborate with Sanofi on intestinal mucosal vaccination by oral administration using AGS\u2019 MEV technology as a vaccinal delivery system"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39","name":"Laure Delhon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","caption":"Laure Delhon"},"url":"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=25774"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25774\/revisions"}],"predecessor-version":[{"id":25775,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/25774\/revisions\/25775"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/21411"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=25774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=25774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=25774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}